Report

  • Home |
  • Reports |
  • Global Biochip Market by Product Type (DNA Chips Market, Lab-On-A-Chip Market, P....
src

Global Biochip Market by Product Type (DNA Chips Market, Lab-On-A-Chip Market, Protein Chips Market & other) and by End-Users/Application (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes & Other) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

The report on the global biochip market analyzes complete scenario i.e., existing as well as future visions of biochip market. It includes detailed overview of biochip market along with market pictures. Additionally, report has included complete data of the various segments in the global biochip market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global biochip market report offers in-depth insights, revenue details, and other vital information regarding the global biochip market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of biochip market.

Market Segmentation:
Segmentation by Type DNA Chips Market
Gene Expression
SNP Genotyping
Cancer Diagnosis & Treatment
Genomics
Drug Discovery
Agricultural Biotechnology
Lab-On-A-Chip Market
Clinical Diagnostics
Genomics
IVD & POC
Proteomics
Drug Discovery
Protein Chips Market
Proteomics
Expression Profiling
Diagnostics
High-Throughput Screening
Drug Discovery
Other 
Cell Arrays
Tissue Arrays 
Segmentation by Application Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, biochip market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global biochip market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Biochip Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each biochip market player.
  • Region-wise and country-wise breakdown of the biochip market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global biochip market.
  • Year-on-year growth of the global biochip market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish biochip market and nurture business as it explains current global market as well as future market.
Chapter 1 Biochip Market Overview
1.1 Product Overview and Scope of Biochip

Chapter 2 Executive Summary  
2.1 Drivers for Biochip Market: 
2.2 Restrain for Biochip Market:
2.3 Opportunity for Biochip Market: 
2.4 Global Biochip market, 2015 - 2027
2.5 Global Biochip market, by Region, 2015 - 2027
2.6 Global Biochip market, by Type, 2015 - 2027
2.7 Global Biochip market, by Application, 2015 - 2027

Chapter 3 Biochip Segment by Types (Product Category) 
3.1 Global Biochip Revenue (USD Million) and Growth Rate (%) Comparison by Types  (2015-2027) 
3.2 Global Biochip Revenue Market Share (%) by Types in 2019
3.3 DNA Chips Market
3.4 Lab-On-A-Chip Market
3.5 Protein Chips Market 
3.6 Other

Chapter 4 Global Biochip Segment by Application 
4.1 Global Biochip Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 Biotechnology and Pharmaceutical Companies
4.3 Hospitals and Diagnostics Centers
4.4 Academic & Research Institutes
4.5 Other

Chapter 5 Global Biochip Market by Regions (2015-2027) 
5.1 Global Biochip Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Biochip Status and Prospect (2015-2027) 
5.3 Europe Biochip Status and Prospect (2015-2027)
5.4 Asia Pacific Biochip Status and Prospect (2015-2027) 
5.5 South America Biochip Status and Prospect (2015-2027) 
5.6 Middle East & Africa Biochip Status and Prospect (2015-2027) 
5.7 Global Biochip Market Size (2015-2027) 
            5.7.1 Global Biochip Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Biochip Market Competition by Manufacturers
6.1 Global Biochip Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Company 1. Abbott Laboratories
            7.1.1 Company 1 Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Biochip Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
            7.1.7 Key Financial Data (2015-2019)
7.2 Company 2. Agilent Technologies
            7.2.1 Company 2 Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Biochip Product Types Specification
            7.2.5 Business Strategy
            7.2.6  Key Financial Data (2015-2019)
7.3 Company 3. PerkinElmer Inc.
            7.3.1 Company 3 Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Biochip Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
            7.3.6 Key Financial Data (2015-2019)
7.4 Company 4. Illumina
            7.4.1 Company 4 Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Biochip Product Types Specification
            7.4.4 Business Strategy
            7.4.5  Key Financial Data (2015-2019)
7.5 Company 5. GE Healthcare
            7.5.1 Company 5 Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Biochip Product Types Specification
            7.5.4 Business Strategy
            7.6.5 Key Financial Data (2015-2019)
7.6 Company 6. Bio-Rad Laboratories Inc.
            7.6.1 Company 6 Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Biochip Product Types Specification
            7.6.4 Business Strategy
            7.6.5  Key Financial Data (2015-2019)
7.7 Company 7. Cepheid Inc.
            7.7.1 Company 7 Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Biochip Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
            7.7.7  Key Financial Data (2015-2019)
7.8 Company 8. Fluidigm Corporation
            7.8.1 Company 8 Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Biochip Product Types Specification
            7.8.4 Business Strategy
            7.8.5  Key Financial Data (2015-2019)
7.9 Company 9. Thermo Fisher Scientific 
            7.9.1 Company 9 Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Biochip Product Types Specification
            7.9.4 Business Strategy
            7.9.5  Key Financial Data (2015-2019)
7.10 Company 10. F. Hoffmann-La Roche AG.
            7.10.1 Company 10 Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Biochip Product Types Specification
            7.10.4 Business Strategy
            7.10.5 Key Financial Data (2015-2019)
            
Chapter 8 Global Biochip Revenue by Regions (2015-2027) 
8.1 Global Biochip Revenue and Market Share (%) by Regions (2015-2027) 

Chapter 9 Global Biochip Revenue by Types
9.1 Global Biochip Revenue and Market Share (%) by Types (2015-2027) 

Chapter 10 Global Biochip Market Analysis by Application
10.1 Global Biochip Revenue (USD Million) and Market Share (%) by Application (2015-2027) 
10.2 Global Biochip Revenue Growth Rate by Application (2015-2027) 

Chapter 11 North America Biochip Market Development Status and Outlook
11.1 North America Biochip Market Size (2015-2027) 
            11.1.1 North America Biochip Market Size by Type (USD Million) (2015-2027) 
11.2 North America Biochip Market Size (2015-2027) 
            11.2.1 North America Biochip Market Size by Application (USD Million) (2015-2027) 
11.3 U.S
            11.3.1 U.S. Biochip market, by Type, 2015 - 2027
            11.3.2 U.S. Biochip market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Biochip market, by Type, 2015 - 2027
            11.4.2 Canada Biochip market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Biochip market, by Type, 2015 - 2027
            11.5.2 Mexico Biochip market, by Application, 2015 – 2027
            
Chapter 12 Europe Biochip Market Development Status and Outlook
12.1 Europe Biochip Market Size (2015-2027) 
            12.1.1 Europe Biochip Market Size by Type (USD Million) (2015-2027) 
12.2 Europe Biochip Market Size (2015-2027) 
            12.2.1 Europe Biochip Market Size by Application (USD Million) (2015-2027) 
12.3 U.K.
            12.3.1 U.K. Biochip market, by Type, 2015 - 2027
            12.3.2 U.K. Biochip market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Biochip market, by Type, 2015 - 2027
            12.4.2 Germany Biochip market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Biochip market, by Type, 2015 – 2027
            12.5.2 France Biochip market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Biochip market, by Type, 2015 – 2027
            12.6.2 Italy Biochip market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Biochip market, by Type, 2015 – 2027
            12.7.2 Spain Biochip market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Biochip market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Biochip market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Biochip Market Development Status and Outlook
13.1 Asia Pacific Biochip Market Size (2015-2027) 
            13.1.1 Asia Pacific Biochip Market Size by Type (USD Million) (2015-2027) 
13.2 Asia Pacific Biochip Market Size (2015-2027) 
            13.2.1 Asia Pacific Biochip Market Size by Application (USD Million) (2015-2027) 
13.3 China
            13.3.1 China Biochip market, by Type, 2015 – 2027
            13.3.2 China Biochip market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Biochip market, by Type, 2015 – 2027
            13.4.2 Japan Biochip market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Biochip market, by Type, 2015 – 2027
            13.5.2 India Biochip market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Biochip market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Biochip market, by Application, 2015 – 2027
            
Chapter 14 South America Biochip Market Development Status and Outlook
14.1 South America Biochip Market Size (2015-2027) 
            14.1.1 South America Biochip Market Size by Type (USD Million) (2015-2027) 
14.2 South America Biochip Market Size (2015-2027) 
            14.2.1 South America Biochip Market Size by Application (USD Million) (2015-2027) 
14.3 Brazil
            14.3.1 Brazil Biochip market, by Type, 2015 – 2027
            14.3.2 Brazil Biochip market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Biochip market, by Type, 2015 – 2027
            14.4.2 Argentina Biochip market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Biochip market, by Type, 2015 – 2027
            14.5.2 Colombia Biochip market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Biochip market, by Type, 2015 – 2027
            14.6.2 Colombia Biochip market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Biochip Market Development Status and Outlook
15.1 Middle East & Africa Biochip Market Size (2015-2027) 
            15.1.1 Middle East & Africa Biochip Market Size by Type (USD Million) (2015-2027) 
15.2 Middle East & Africa Biochip Market Size (2015-2027) 
            15.2.1 Middle East & Africa Biochip Market Size by Application (2015-2027) 
15.3 UAE
            15.3.1 UAE Biochip market, by Type, 2015 – 2027
            15.3.2 UAE Biochip market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Biochip market, by Type, 2015 – 2027
            15.4.2 South Africa Biochip market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Biochip market, by Type, 2015 – 2027
            15.5.2 Egypt Biochip market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Biochip market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Biochip market, by Application, 2015 – 2027
            
Chapter 16 Biochip Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Research Findings and Conclusion
 
No Methodology
Global Biochip Market Trends:
The global biochip is estimated to be worth USD 14billion in 2019 and is projected to reach USD 62.82billion by 2027, at a CAGR of 20.63% from 2020 to 2027. 

A biochip is a collection of microarrays organized on a solid substrate, allowing thousands of complex biochemical reactions, to determine various biological data, for instance, decoding the genes in less time. The biochip-based analysis is primarily used for on-site diagnosis. Biochips also undergo other diagnostic applications such as microarray technique, microfluidic technologies, & biosensors. A biochip can also provide analytical data regarding organic molecules associated with the living organisms. It helps in identifying airborne toxins, environmental pollutants, gene sequences, & other biochemical constituents.

The growth of the global biochip industry is largely driven by an increase in cancer occurrence, autoimmune diseases, and viral infections. The expansion of the geriatric population, the rise of biochip uses, and high acceptance of personalized drugs are also factors that boost the market growth. Nevertheless, the market growth is hampered largely by factors such as high biochip costs and absence of awareness. In contrast, increased R&D and public funding are anticipated to offer lucrative business growth possibilities in untapped markets in developing economies.

Global Biochip Market, By Type:
Based on the type, the global market is categorized into DNA Chips Market, Lab-On-A-Chip Market, Protein Chips Market & other. On the basis of type DNA Chips Market, accounted for largest share of total revenue generated due to the increasing use of DNA chip products. The use of DNA chip has empowered the scientific community by enabling measurement of the expression levels of large numbers of genes simultaneously. A DNA chip involves an array of microscopic “spots” each carrying numerous single-stranded oligonucleotides and are widely being used in biomedical research activities. Thus due to its huge utilization led to the growth of this segment which is fueling the biochip market.

Global Biochip, By Application:
Based on the application, the global market is categorized into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes & Other. The demand of Global Biochip Market is highest from Biotechnology and Pharmaceutical Companies due to the numerous features offered by it. The utilization rate of biochips in biotechnology and pharmaceutical companies was high. The hospitals & diagnostics is the second fastest growing segment due to the adoption of biochip in new drug discovery as well as in point-of-care diagnostics has increased the consumption of these biochips in hospitals & diagnostics centers. Thus all these factors led to increase usage of biochips in this sectors which is propelling the growth of the biochip market. 

Global Biochip market, By Region:
Report covers the region wise analysis, global Biochip market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America leads the global Biochip market share followed by Europe and Asia Pacific. While the North America leads the global Biochip market due to the factors such as presence of well-established players, advanced informatics infrastructure, presence of experts and skilled workforce, and ongoing genomic R & D practices on a large scale in the region. While the rising R & D investments in genomic research is driving the growth of the market. Moreover, growing awareness regarding genetic tests for disease risk assessment and prevention is anticipated to have a positive impact on the growth of the regional market.

Major Market Players:
The research study includes profiles of leading companies operating in the global biochip market. Key players profiled in the report include: Abbott Laboratories, Agilent Technologies, PerkinElmer Inc., Fluidigm Corporation, Illumina, GE Healthcare, Bio-Rad Laboratories Inc., Cepheid Inc., Thermo Fisher Scientific and F. Hoffmann-La Roche AG.
Thermo Fisher Scientific Inc. completed the acquisition of Affymetrix Inc., a leading provider of cellular and genetic analysis products. This acquisition helped Thermo Fisher to strengthen its leadership in biosciences, as well as acquire new genetic analysis capabilities to better serve clinical and applied markets.

Global Biochip Market Report Scope
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type DNA Chips Market, Lab-On-A-Chip Market, Protein Chips Market & other
Applications Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes & Other
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Abbott Laboratories, Agilent Technologies, PerkinElmer Inc., Fluidigm Corporation, Illumina, GE Healthcare, Bio-Rad Laboratories Inc., Cepheid Inc., Thermo Fisher Scientific and F. Hoffmann-La Roche AG

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global biochip market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Biochip Market: Product analysis
•     DNA Chips Market
            o    Gene Expression
            o    SNP Genotyping
            o    Cancer Diagnosis & Treatment
            o    Genomics
            o    Drug Discovery
            o    Agricultural Biotechnology
•    Lab-On-A-Chip Market
            o    Clinical Diagnostics
            o    Genomics
            o    IVD & POC
            o    Proteomics
            o    Drug Discovery
•    Protein Chips Market
            o    Proteomics
            o    Expression Profiling
            o    Diagnostics
            o    High-Throughput Screening
            o    Drug Discovery
•    Other 
            o    Cell Arrays
            o    Tissue Arrays

Global Biochip Market: Application analysis
•    Biotechnology and Pharmaceutical Companies
•    Hospitals and Diagnostics Centers
•    Academic & Research Institutes
•    Other

Market, By regions:
In addition, biochip report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
•    North America (U.S., Canada, Mexico)
•    Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
•    Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
•    Latin America (Brazil, Rest of L.A.)
•    Middle East and Africa (Turkey, GCC, Rest of Middle East)